Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Accounts Payables (2020 - 2025)

NeuroPace has reported Accounts Payables over the past 6 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Accounts Payables at $2.2 million for Q4 2025, down 24.95% from a year ago — trailing twelve months through Dec 2025 was $2.2 million (down 24.95% YoY), and the annual figure for FY2025 was $2.2 million, down 24.95%.
  • Accounts Payables for Q4 2025 was $2.2 million at NeuroPace, down from $4.6 million in the prior quarter.
  • Over the last five years, Accounts Payables for NPCE hit a ceiling of $4.7 million in Q2 2025 and a floor of $968000.0 in Q2 2021.
  • Median Accounts Payables over the past 5 years was $2.2 million (2022), compared with a mean of $2.3 million.
  • Peak annual rise in Accounts Payables hit 112.5% in 2025, while the deepest fall reached 24.95% in 2025.
  • NeuroPace's Accounts Payables stood at $1.4 million in 2021, then soared by 55.81% to $2.1 million in 2022, then rose by 8.62% to $2.3 million in 2023, then increased by 26.67% to $3.0 million in 2024, then dropped by 24.95% to $2.2 million in 2025.
  • The last three reported values for Accounts Payables were $2.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.7 million (Q2 2025) per Business Quant data.